Corient Capital Partners’s Vulcan Materials VMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.45M Buy
10,221
+23
+0.2% +$3.74K 0.11% 162
2022
Q2
$1.45M Sell
10,198
-515
-5% -$85K 0.11% 170
2022
Q1
$1.97M Buy
10,713
+693
+7% +$129K 0.13% 147
2021
Q4
$2.08M Buy
10,020
+1,096
+12% +$212K 0.14% 144
2021
Q3
$1.51M Buy
8,924
+1,794
+25% +$321K 0.11% 171
2021
Q2
$1.24M Buy
7,130
+1,890
+36% +$338K 0.09% 196
2021
Q1
$885K Buy
5,240
+276
+6% +$44.8K 0.08% 211
2020
Q4
$736K Sell
4,964
-1,054
-18% -$150K 0.07% 213
2020
Q3
$816K Sell
6,018
-129
-2% -$16.2K 0.09% 188
2020
Q2
$712K Buy
+6,147
New +$673K 0.09% 206
2020
Q1
Sell
-1,816
Closed -$261K 488
2019
Q4
$261K Buy
1,816
+100
+6% +$14.3K 0.03% 387
2019
Q3
$260K Buy
1,716
+77
+5% +$10.9K 0.04% 366
2019
Q2
$225K Buy
+1,639
New +$209K 0.03% 349

Other funds holding VMC

Corient Capital Partners's VMC Position: Q3 2022 in Review

Corient Capital Partners increased its Vulcan Materials (VMC) stake by 0.23% in Q3 2022, buying an estimated $3.74K and bringing the position to 10,221 shares worth $1.45M. The position accounts for 0.11% of the portfolio, ranked #162.

Corient Capital Partners first reported a position in VMC in Q2 2019 and has held it in 13 quarters since. The position peaked at $2.08M in Q4 2021. 677 funds tracked by Wall St. Rank hold VMC as of Q3 2022.

  • Corient Capital Partners held 10,221 shares of Vulcan Materials worth $1.45M as of Q3 2022.
  • Corient Capital Partners bought 23 Vulcan Materials shares in Q3 2022, an estimated $3.74K.
  • Vulcan Materials made up 0.11% of Corient Capital Partners's portfolio in Q3 2022, its #162 holding.
  • Corient Capital Partners first reported a position in Vulcan Materials in Q2 2019 and has held it in 13 quarters since.
  • Corient Capital Partners's Vulcan Materials position peaked at $2.08M in Q4 2021.
  • 677 funds tracked by Wall St. Rank held Vulcan Materials as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.